Biomet expects to use the net proceeds of this offering to fund its tender offer for any and all of its outstanding 10⅜ / 11⅛ percent senior toggle notes due 2017, including related fees and expenses, and to purchase, redeem, defease or otherwise acquire or retire its outstanding indebtedness.
More Articles on Orthopedic Devices:
7 Biggest Factors Impacting Spine Research & Innovation
Wright Medical Group Slapped With Subpoena for Hip Device Documents
